Literature DB >> 2360502

Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements.

J M Neutel1, H Schnaper, D G Cheung, W F Graettinger, M A Weber.   

Abstract

Whole-day automated ambulatory blood pressure (BP) monitoring was used to assess the duration of the antihypertensive actions of the beta-blockers atenolol (50 to 100 mg; n = 20) and acebutolol (400 to 800 mg; n = 19) each given once daily at 9 AM. When compared with its pretreatment 24-hour average, atenolol decreased diastolic BP by 10 +/- 2 mm Hg (p less than 0.01) and systolic BP by 12 +/- 2 mm Hg (p less than 0.01). Acebutolol decreased the 24-hour diastolic BP by 11 +/- 1 mm Hg (p less than 0.01) and systolic BP by 13 +/- 2 mm Hg (p less than 0.01). More specifically, a comparison of the two drugs during the final 6 hours (3 AM to 9 AM) of the dosing interval showed that the mean decrease in diastolic BP of 10.2 +/- 1.5 mm Hg with acebutolol was greater (p less than 0.05) than the decrease of 6.2 +/- 1.3 mm Hg with atenolol. Moreover, this final 6-hour effect of atenolol was less (p less than 0.01) than that observed during the first 18 hours of the day. The late effects of acebutolol did not change significantly from its early effects. The two agents also differed in their trough (final 2-hour decrease in diastolic BP) and peak (maximum 2-hour decrease in diastolic BP) effects: for atenolol the peak-to-trough difference was 7.8 +/- 3.1 mm Hg (p less than 0.05), whereas for acebutolol it was 3.8 +/- 4.2 mm Hg (N.S.). This study confirms the efficacy of atenolol and acebutolol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360502     DOI: 10.1016/0002-8703(90)90174-v

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

Review 1.  The implications of noncompliance with antihypertensive medication.

Authors:  B Girvin; G D Johnston
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

Review 2.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 3.  How important is 24-hour control of blood pressure?

Authors:  T Morgan; A Anderson
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

4.  Letters to the editor.

Authors: 
Journal:  Ochsner J       Date:  2013

5.  Comparison of casual, ambulatory and self-measured blood pressure in a study of nitrendipine vs bisoprolol.

Authors:  T Mengden; B Bättig; M Schubert; T Jeck; B Weisser; C Buddeberg; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 6.  Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence.

Authors:  Janet B McGill
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

7.  Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension.

Authors:  P Greminger; P M Suter; D Holm; R Kobelt; W Vetter
Journal:  Clin Investig       Date:  1994-11

Review 8.  Current and future status of beta-blockers in the treatment of hypertension.

Authors:  Steven G Chrysant; George S Chrysant; Billy Dimas
Journal:  Clin Cardiol       Date:  2008-06       Impact factor: 2.882

Review 9.  Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux; Francis Verbeke; Esmeralda Castillo-Rodriguez; Alberto Ortiz
Journal:  Toxins (Basel)       Date:  2018-06-12       Impact factor: 4.546

10.  The antihypertensive efficacy and safety of a chronotherapeutic formulation of propranolol in patients with hypertension.

Authors:  Domenic A Sica; Joel M Neutel; Michael A Weber; Neil Manowitz
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.